|
From April 2010 to March 2011, IBN established 26 new collaborations with the Singapore Immunology Network (2), Eidgenossische Technische Hochschule Zurich, Changchun Institute of Applied Chemistry, Institute of High Performance Computing, European Synchotron Radiation Facility, Genome Institute of Singapore, University of Wisconsin-Madison, Singapore Bioimaging Consortium, NanoTemper Technologies, National Neuroscience Institute, National Cancer Center Singapore, National University Health System (4), Kurume University, Singapore Eye Research Institute, National University of Singapore, Institute of Microelectronics, Korean Research Institute of Bioscience and Biotechnology, University of California, Santa Barbara, Centre National de Recherche Scientifique, Nanyang Technological University, Singapore Institute for Clinical Sciences, and Bayer (Southeast Asia).
IBN researchers have established many fruitful research collaborations both locally and internationally. We have a total of 15 active collaborations with our sister research institutes under the Biomedical Research Council (BMRC) and the Science and Engineering Research Council (SERC), 30 academic collaborations, 45 clinical collaborations, and 15 industrial collaborations.
A*STAR Collaborators:
- Biomedical Research Council
- Bioinformatics Institute
- Bioprocessing Technology Institute
- Genome Institute of Singapore (2)
- Institute of Medical Biology
- Institute of Microelectronics
- Institute of Molecular and Cell Biology (2)
- Singapore Bioimaging Consortium
- Singapore Immunology Network (2)
- Singapore Institute for Clinical Sciences
- Science and Engineering Research Council
- Institute of Infocomm Research
- Institute of High Performance Computing (2)
Academic Collaborators:
- Centre National de Recherce Scientifique, France
- Changchun Institute of Applied Chemistry, China
- Cornell University, USA
- European Synchrotron Radiation Facility, France (2)
- ETH Zurich, Switzerland
- Helmholtz Center Munich, Germany
- Instituto de Neurobiología, Mexico
- Korean Research Institute of Bioscience and Biotechnology, Korea
- Ludwig-Maximilian University Munich, Germany
- Massachusetts Institute of Technology, USA (2)
- Max Planck Institute for Polymer Research, Germany
- Nanyang Technological University, Singapore (3)
- National Energy Technology Laboratory, Department of Energy, USA
- National University of Singapore, Singapore (6)
- Technical University of Darmstadt, Germany
- University of California, Santa Barbara, USA
- University of Minnesota, USA
- University of Oslo, Norway
- University of Sydney, Australia
- University of Wisconsin-Madison, USA
- Weismann Institute of Science, Israel
Clinical Collaborators:
- Imperial College, London, UK
- Kurume University, Japan (3)
- Loma Linda Medical Center, USA
- Medical University of South Carolina, USA
- National Cancer Center, Singapore (2)
- National Neuroscience Institute, Singapore
- National Skin Center, Singapore
- National University Health System, Singapore (13)
- National University Hospital, Singapore (2)
- National University of Singapore (3)
- Oklahoma Medical Research Foundation, USA
- Shanghai Jiao Tong University, China
- Singapore Eye Research Institute, Singapore (4)
- Singapore General Hospital, Singapore
- St. Jude Children's Research Hospital, USA
- Sun Yat-Sen University Cancer Center, China
- The Brigham and Women's Hospital, Inc., USA
- The University of Texas MD Anderson Cancer Center, USA (2)
- University of Chicago, USA
- Veterans Affairs Boston Healthcare System, USA
- Zhejiang University, China (2)
- Zhujiang Hospital, China
Industrial Collaborators:
- 3D Matrix
- Bayer
- Carl Zeiss (2)
- Celblos
- Curiox Biosystems
- Hisaka
- IBM
- Johnson & Johnson
- NanoTemper Technologies
- Olympus
- SBH Sciences
- SG Molecular Diagnostics
- Tokyo Chemical Industry Co.
- Yushi Seihin
|